Physician profile
Daniel Matthew Bender
NPI 1427585488
$557.91
in general payments reported to CMS, 2019-2025
11 companies · $35.32 in 2025
The $35.32 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $49.67 · 2020: $15.28 · 2021: $28.70 · 2022: $88.23 · 2023: $232 · 2024: $109 · 2025: $35.32.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $376.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $376.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $130.91 | 2021-2023 | Vraylar |
| Astrazeneca Pharmaceuticals LP | $107.57 | 2022-2024 | Breztri, Farxiga |
| Glaxosmithkline, LLC. | $105.26 | 2021-2025 | Trelegy Ellipta, Shingrix, Arexvy |
| Medtronic, INC. | $71.52 | 2022-2023 | Minimed 770g |
| Lilly USA, LLC | $44.56 | 2023-2024 | Mounjaro, Emgality, Jardiance |
| Mylan Specialty L.P. | $19.60 | 2019 | |
| Novo Nordisk INC | $18.03 | 2025 | Wegovy |
| Merck Sharp & Dohme LLC | $17.52 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $15.28 | 2020 | |
| Boston Scientific Corporation | $15.11 | 2024 | Watchman Access System |
| Currax Pharmaceuticals LLC | $12.55 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Bender listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.